HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $668,882 | +99.1% | 17,510 | +129.2% | 0.20% | +17.9% |
Q2 2022 | $336,000 | +122.5% | 7,639 | -25.9% | 0.17% | +110.0% |
Q4 2018 | $151,000 | -53.7% | 10,313 | -42.6% | 0.08% | -43.7% |
Q3 2018 | $326,000 | +34.2% | 17,965 | +44.5% | 0.14% | +140.7% |
Q1 2018 | $243,000 | -68.7% | 12,429 | -67.6% | 0.06% | -74.1% |
Q4 2017 | $777,000 | +164.3% | 38,345 | +126.9% | 0.23% | +174.7% |
Q3 2017 | $294,000 | – | 16,900 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |